From the Journals
Alcohol abuse goes untreated in HCV patients
HCV patients with alcohol-use disorder often don’t get the treatment they need.
News from the AGA
Announcing the 2018 Section Research Mentor Award recipients
The AGA Institute Council Section Research Mentor Award acknowledges AGA members for their achievements as outstanding mentors in a specific area...
News from the FDA/CDC
FDA approves Doptelet for liver disease patients undergoing procedures
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure....
News from the AGA
Psychotherapy helps patients with chronic digestive disorders
New AGA Clinical Practice Update explains benefits of psychogastroenterology for patients.
News from the AGA
AGA Fellows application period now open
The AGA Fellows program recognizes long-term AGA members for their superior work in clinical private or academic practice and in basic or clinical...
News from the AGA
AGA hosted productive Hill meeting advocating for GIs
AGA stressed that MIPS reporting and scoring needs to be simplified to make it less administratively burdensome and costly for physicians.
From the Journals
IBD upped Parkinson’s risk in large study
The adjusted hazard ratio was 1.22.
From the Journals
Patients with CF at increased risk for GI cancers
Patients who received lung transplants for cystic fibrosis are at especially high risk for developing gastrointestinal cancers.
Feature
Female physicians face enduring wage gap
Earnings for women in the 50 largest metro areas came up short by 27.7% last year.
Conference Coverage
Where the latest HCV drug combos fit in
MAUI, HAWAII – The biggest remaining challenge in the treatment of hepatitis C is to gain improved access to therapy, according to Steven L. Flamm...
Feature
Uninsured rate on the rise
New survey shows that Medicaid expansion lessened the effect.
From the Journals
Study: Which endoscopy malpractice claims end in payment?
In a small study of medical malpractice cases, endoscopic retrograde cholangiopancreatography most often resulted in payouts to plaintiffs.
Conference Coverage
Celiac disease: Can biopsy be avoided?
LAS VEGAS – Some medical societies say the diagnosis can be made with antibody titers and symptoms alone, others disagree.
From the Journals
Class III obesity increases risk of acute on chronic liver failure in cirrhotic patients
Patients with a BMI greater than or equal to 40 kg/m2 with decompensated cirrhosis are at greater risk of developing acute on chronic...
From the Journals
Very few infants born to HCV-infected mothers receive testing
Despite increasing prevalence of hepatitis C virus infection in pregnant women, infants exposed to the disease are screened at a very low rate.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
Conference Coverage
New drugs provide new options in HCC
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
Conference Coverage
Hepatic adenoma assessment: Wait longer to avoid overtreatment?
LAS VEGAS – In women it may take longer after oral contraceptive withdrawal than currently recommended for hepatic adenomas to regress.
Conference Coverage
Treatment of HCV in special populations
MAUI, HAWAII – Acute hepatitis C infection sometimes warrants treatment.
AGA Tech Summit
Update on AGA-Medtronic Research and Development Pilot Award in Technology
BOSTON – IBS and SIBO result from several distinct pathophysiologic mechanisms, each of which are associated with their own distinct microbial and...
Conference Coverage
Constipation on opioids? Follow these three steps to ID the true cause
LAS VEGAS – Treatment will depend on whether the patient had constipation before taking opioids.
Most Viewed
- Where the latest HCV drug combos fit in
- AGA Clinical Practice Update: Screening for Barrett’s esophagus requires consideration for those most at risk
- Hep B therapy: Indefinite or FINITE for e-negative patients?
- Female physicians face enduring wage gap
- Alpha fetoprotein boosted detection of early-stage liver cancer
Commentary
Question 1 of 5
News From the AGA
- Announcing the 2018 Section Research Mentor Award recipients
- Psychotherapy helps patients with chronic digestive disorders
- AGA Fellows application period now open
- AGA hosted productive Hill meeting advocating for GIs
- Federal spending agreement includes wins for medical community
- AGA leaders recognized for their contributions to the field
- Save the date for the 2019 Crohn’s & Colitis Congress
- AGA seeks regulatory relief for GIs
- Sessions at DDW® 2018 designed for trainees and early career GIs
- Better manage acute pancreatitis to improve patient outcomes
From the AGA Journals
- AGA Clinical Practice Update: Screening for Barrett’s esophagus requires consideration for those most at risk
- PPI use not linked to cognitive decline
- Alpha fetoprotein boosted detection of early-stage liver cancer
- One in seven Americans had fecal incontinence
- Heavy drinking did not worsen clinical outcomes from drug-induced liver injury
- Model predicted Barrett’s esophagus progression
- VIDEO: Biomarker accurately predicted primary nonfunction after liver transplant
- VIDEO: Pioglitazone benefited NASH patients with and without T2DM
- AGA Clinical Practice Update: Incorporating psychological care in the management of chronic digestive diseases
- Opioids linked to mortality in IBD
